Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy

Because of its anabolic effects on muscle, testosterone is being explored as a function-promoting anabolic therapy for functional limitations associated with aging; however, concerns about testosterone’s adverse effects on prostate have inspired efforts to develop strategies that selectively increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasuja, Ravi, Costello, James C, Singh, Rajan, Gupta, Vandana, Spina, Catherine S, Toraldo, Gianluca, Jang, Hyeran, Li, Hu, Serra, Carlo, Guo, Wen, Chauhan, Pratibha, Narula, Navjot S, Guarneri, Tyler, Ergun, Ayla, Travison, Thomas G, Collins, James J, Bhasin, Shalender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331775/
https://www.ncbi.nlm.nih.gov/pubmed/24305501
http://dx.doi.org/10.1111/acel.12174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331775/
https://www.ncbi.nlm.nih.gov/pubmed/24305501
http://dx.doi.org/10.1111/acel.12174

Ejemplares similares